NCT07552116 Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia
| NCT ID | NCT07552116 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Badr University |
| Condition | Pneumonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-06 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-06 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.
Eligibility Criteria
Inclusion Criteria: * Dawn Syndrome children with pneumonia * Mean age of 3.73±1.82 year * Children were in the first attack of bronchopneumonia. Exclusion Criteria: * Other chest disease
Contact & Investigator
Mona Mohamed Abdelkhalek, assistance prof
PRINCIPAL INVESTIGATOR
Badr University
Frequently Asked Questions
Who can join the NCT07552116 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 5 Years, studying Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07552116 currently recruiting?
Yes, NCT07552116 is actively recruiting participants. Contact the research team at mona.abdelkhalek@buc.edu.eg for enrollment information.
Where is the NCT07552116 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07552116 clinical trial?
NCT07552116 is sponsored by Badr University. The principal investigator is Mona Mohamed Abdelkhalek, assistance prof at Badr University. The trial plans to enroll 40 participants.